acc Archives - AudioMedica.com

Medical News Interviews

Tagged: acc

2
- in Cardiovascular
- — 30 Apr, 2008
Bivalirudin For Angioplasty: Expensive Heparin?
Tony Gershlick
Tony Gershlick, University of Leicester
Adnan Kastrati, Deutsches Herzzentrum, Munich
Using bivalirudin instead of heparin during angioplasty wasn’t any better for preventing death, MI or urgent revascularisation in the 4,500-patient ISAR-REACT 3 study presented at the
…
Read more
0
- in Cardiovascular
- — 15 Apr, 2008
Remove Thrombus Before Primary Angioplasty!
Felix Zijlstra
Felix Zijlstra, University Medical Center Groningen, The Netherlands
Thrombus aspiration before percutaneous coronary intervention for acute myocardial infarction has multiple benefits, according to data from the 1000-patient TAPAS study presented at the ACC meeting. Senior investigator Felix
…
Read more
0
- in Cardiovascular
- — 8 Apr, 2008
Never Too Old For Hypertension Treatment!

Nigel Beckett

Nick Boon
Nigel Beckett, Imperial College, London
COMMENT: Nick Boon, British Cardiovascular Society, London
Even very old patients benefit greatly if you treat their hypertension. This is the finding of the randomized HYVET study of 4,000 patients with
…
Read more
0
- in Cardiovascular
- — 6 Apr, 2008
Routine Angioplasty Recommended After Thrombolysis

Warren Cantor

Tony Gershlick
REFERENCE: Abstract 2404-3 SCAI-ACCi2 Late-Breaking Clinical Trials II: Acute Myocardial Infarction
Warren Cantor, University of Toronto
COMMENT: Tony Gershlick, Leicester University
A new study has shown important gains from adding angioplasty routinely to therapy for all
…
Read more
0
- in Cardiovascular
- — 27 Mar, 2007
Audio Journal of Cardiovascular Medicine: “EXACT” Study: Carotid Stenting Benefits Are Maintained in the Real World
WILLIAM GRAY, Columbia University, New York
REFERENCE: Abstract 2409-5, American College of Cardiolgy New Orleans
The benefits of carotid stenting as compared with surgery have been maintained in real-world settings since USA-approval of the technique in 2004, according to William
…
Read more
0
- in Cardiovascular
- — 27 Mar, 2007
“RADIANCE-1” Study: Cholesteryl Ester Transfer Protein Inhibitor Fails to Benefit Patients with Familial Hypercholesterolemia
JOHN KASTELEIN, Academic Medical Center, Amsterdam
REFERENCE: Abstract 407-7, American College of Cardiolgy New Orleans
A drug which raises HDL and reduces circulating levels of LDL has nevertheless failed to reduce atherosclerotic progression in patients with familial hypercholesterolemia. This disappointing
…
Read more
0
- in Cardiovascular
- — 27 Mar, 2007
“ERASE” Trial: Infusions of Reconstituted HDL Treat Atherosclerosis in Patients with Acute Coronary Syndromes
JEAN-CLAUDE TARDIF, Montreal Heart Institute
REFERENCE: Abstract 405-10, American College of Cardiolgy New Orleans
Improvements in atheroma plaque have been achieved by infusing patients who have acute coronary syndromes with reconstituted high density lipoprotein, HDL, according to investigators from the
…
Read more
1
- in Cardiovascular
- — 26 Mar, 2007
COURAGE Trial: Optimal Medical Therapy Alone is Sufficient for Patients with Stable Angina: Adding PCI Does Not Help – ILLUSTRATE Study Shows Torcetrapib Raises HDL But Fails to Lower Coronary Risk
STEVEN NISSEN, Cleveland Clinic, OH
REFERENCE: N Engl J Med 2007 356
Reporting from: American College of Cardiolgy New Orleans
Two big studies published in the New England Journal of Medicine and presented simultaneously at the American College of Cardiology
…
Read more
0
- in Cardiovascular
- — 25 Mar, 2007
Rapid Genotype Assay for Individualized Warfarin Dosing

Jeffrey Anderson

Douglas Zipes
JEFFREY ANDERSON, University of Utah, Salt Lake City
COMMENT: DOUGLAS ZIPES, University of Indiana, Indianapolis
REFERENCE: Abstract 1020-89, American College of Cardiology New Orleans
The hope of refining treatments for cardiovascular disease by genotyping patients to
…
Read more
0
- in Cardiovascular
- — 25 Mar, 2007
Thrombin Receptor Antagonist: Advantages in Percutaneous Coronary Intervention?
DAVID MOLITERNO, University of Kentucky, Lexington
REFERENCE: American College of Cardiolgy New Orleans, March 24th Late Breaking Trials
An oral thrombin receptor antagonist, SCH 530348 has proved safe and effective, and may be better than conventional anti-coagulation treatments for patients
…
Read more